ST Segment Elevation Myocardial Infarction Clinical Trials

9 recruitingLast updated: May 29, 2026

There are 9 actively recruiting st segment elevation myocardial infarction clinical trials across 6 countries. Studies span Not Applicable, Phase 4, Early Phase 1, Phase 2. Top locations include Aalborg, Region Nord, Denmark, Aarhus N, Denmark, Asyut, Asyut Governorate, Egypt. Updated daily from ClinicalTrials.gov.


ST Segment Elevation Myocardial Infarction Trials at a Glance

9 actively recruiting trials for st segment elevation myocardial infarction are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Aalborg, Aarhus N, and Asyut. Lead sponsors running st segment elevation myocardial infarction studies include Beijing Anzhen Hospital, Fundación Interhospitalaria para la Investigación Cardiovascular FIC, and Assiut University.

Browse st segment elevation myocardial infarction trials by phase

Treatments under study

About ST Segment Elevation Myocardial Infarction Clinical Trials

Looking for clinical trials for ST Segment Elevation Myocardial Infarction? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ST Segment Elevation Myocardial Infarction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ST Segment Elevation Myocardial Infarction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Ischemic Heart DiseaseST Segment Elevation Myocardial Infarction
Thomas Engstrom150 enrolled1 locationNCT02445885
Recruiting
Phase 4

Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction

Acute Myocardial Infarction (AMI)NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
University of Aarhus5,076 enrolled10 locationsNCT06710184
Recruiting
Phase 4

Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia

Coronary Artery EctasiaSTEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)+1 more
Instituto Nacional de Cardiologia Ignacio Chavez326 enrolled1 locationNCT07511257
Recruiting
Not Applicable

Ischemic Postconditioning in STEMI Patients Treated With Primary PCI

ST Segment Elevation Myocardial Infarction
Rigshospitalet, Denmark1,800 enrolled1 locationNCT03787745
Recruiting

Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease

Coronary Arterial Disease (CAD)ST Elevation Myocardial InfarctionSilent Ischemia+3 more
Fundación Interhospitalaria para la Investigación Cardiovascular FIC1,118 enrolled1 locationNCT07444957
Recruiting
Not Applicable

The Thrombus Aspiration During PCI After Thrombolysis in STEMI

ST Segment Elevation Myocardial Infarction
Shenghua Zhou3,500 enrolled1 locationNCT06654453
Recruiting
Early Phase 1

Short-Term Outcomes of Early Administration of Colchicine in Non-ST Segment Elevation Myocardial Infarction Patients Treated With Drug-Eluting Stents.

Non ST Segment Elevation Myocardial Infarction
Assiut University140 enrolled1 locationNCT07143136
Recruiting
Phase 2

Doxycycline to Protect Heart Muscle After Heart Attacks

Heart FailureST Segment Elevation Myocardial Infarction
University of Alberta170 enrolled1 locationNCT03508232
Recruiting
Not Applicable

Treatment of ACuTe Coronary Syndromes With Low-dose colchICine

Acute Coronary SyndromeColchicineUnstable Angina+2 more
Beijing Anzhen Hospital6,574 enrolled1 locationNCT06215989